Welcome to JenaValve Technology

The JenaValve™ Pericardial Transcatheter Aortic Valve Replacement (TAVR) System is designed to treat symptomatic, severe aortic stenosis and symptomatic, severe aortic regurgitation using a single valve prosthesis construct. Unlike other TAVR designs, this technology does not require rapid pacing. By virtue of its anatomically-based locator fixation and dual sealing valve design, the JenaValve Pericardial TAVR System is intended to enable ease of use, reduced risks of paravalvular regurgitation and need for permanent pacing, and durability of patient hemodynamic outcomes.

The unique JenaValve technology comprises a porcine pericardial trileaflet valve mounted on a low profile nitinol self-expanding frame with integral locators that engage with the native valve cusps and leaflets. State of the art lower profile delivery systems enable both transfemoral and transapical delivery, and facilitate visualization and repositioning as desired prior to valve implant.

Exclusively for Investigational Use

CAUTION: Investigational Device. Limited by federal (or United States) law to investigational use only.

For illustration, a short animation of transfemoral delivery and deployment will be available soon: